Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up
Abstract Aims To increase the effectiveness of percutaneous coronary interventions (PCI) in patients with ostium coronary artery lesions: left arterial descending (LAD) or left circumflex (LCx) – pseudobifurcations. Methods 220 patients were included in the study. Inclusion criteria: ostium atherosl...
Gespeichert in:
Veröffentlicht in: | European heart journal 2021-10, Vol.42 (Supplement_1) |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Aims
To increase the effectiveness of percutaneous coronary interventions (PCI) in patients with ostium coronary artery lesions: left arterial descending (LAD) or left circumflex (LCx) – pseudobifurcations.
Methods
220 patients were included in the study. Inclusion criteria: ostium atheroslerotic lesions of left arterial descending (LAD) or left circumflex (LCx) >70% according to angiography and optical coherence tomography (OCT); myocardial ischemia according the FFR measurement. According OCT data, all patients were devoiced into 2 groups. In I group (n=110) according to OCT, atherosclerotic plaque spread from the ostium of LAD and/or LCx to the left main coronary artery (LMCA), and in group II (n=110) - the plaque did not spread into the LMCA. In Group I all patients were initially treated with “Provisional T” stenting of the LMCA, and in Group II – precision stenting of the ostium LAD or LCx. Primary endpoints: frequency of MACE (death, MI, revascularizations).
Results
The long-term results after 5-years were observe in 98 patients from group I and 92 patients from group II. The survival rate of patients from group I and II, free from cardiac events, were 94.9±4.03 and 81.5±3.23, respectively (p0.05). Myocardial infarction were observed in 2 (2.04%) patients from group I and 5 (5.43%) patients from group II (p>0.05). The target lesion revascularization (TLR) was performed in 3 patients (3.06%) in group I, and in 12 patients (13.04%) in group II (p |
---|---|
ISSN: | 0195-668X 1522-9645 |
DOI: | 10.1093/eurheartj/ehab724.1227 |